Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided botulinum toxin A infiltration for chronic anal fissure
2021-002819-60Phase 4Active
- Sponsor
- Hospital Universitario de Burgos
- Start
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of botulinum toxin type A in chronic anal fissure (CAF) (2 arms), sponsored by Hospital Universitario de Burgos. Primary endpoints: Fissure healing, Recurrence and 1 more. Started Jun 2021; status: active.
02
Drugs
botulinum toxin type A
03
Conditions
chronic anal fissure (CAF)
Beyond the preview
Go deeper on 2021-002819-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002819-60.